Literature DB >> 660885

Isoniazid and bile duct cancer.

A B Lowenfels, J Norman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 660885     DOI： 10.1001/jama.1978.03290050024007

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 2.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

Review 3.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Metabolic studies on the possible mode of action of isoniazid tumorigenicity.

Authors:  S V Bhide; G B Maru; N B Mate; M Menon; P Gangadharan
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

Review 5.  A Review of the Etiology and Epidemiology of Gallbladder Cancer: What You Need to Know.

Authors:  Sattam A Halaseh; Shahed Halaseh; Raed Shakman
Journal:  Cureus       Date:  2022-08-22

Review 6.  Epidemiology of gallbladder cancer.

Authors:  Prashanth Rawla; Tagore Sunkara; Krishna Chaitanya Thandra; Adam Barsouk
Journal:  Clin Exp Hepatol       Date:  2019-05-23

7.  Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt.

Authors:  Amit Gupta; Sweety Gupta; Rohik Anjum T Siddeek; Jaine John Chennatt; Tanuj Singla; Deepak Rajput; Navin Kumar; Amit Sehrawat; Sanjeev Kishore; Manoj Gupta
Journal:  J Carcinog       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.